多器官联合移植

1例腹腔多器官联合移植病人的手术配合

Experience of nursing coordination of a case undergoing combined multiple organs transplantation of abdominal cavity

结论多器官联合移植术后采用ATG、抗CD25单克隆抗体诱导，FK506、MMF及激素三联维持治疗是安全有效的，用药期间应监测移植物功能和FK506的血药浓度，防止排斥反应和FK506中毒。

Conclusion Induction therapy with ATG and anti-CD25 monoclonal antibody and maintaining therapy including FK506 , MMF and steroids after multiple organ transplantation are safe and effective . Monitoring of graft function and FK506 level is important for avoiding the rejection and nephrotoxicity caused by FK506 .

目的探讨多器官联合移植术后的免疫抑制治疗方法。

Objective To study immunosuppressive therapy after multiple organ transplantation .

腹部多器官联合移植的基础与临床研究

Basic and Clinical Study of Abdominal Multiorgan Combined Transplantation

猪腹部多器官联合移植术中血流动力学变化及处理

Hemodynamic changes and corresponding protective measures after orthotopic abdominal multivisceral transplantation in pigs

临床腹部多器官联合移植术中血液生化的改变

Biochemical changes during the clinical abdominal multivisceral transplantation

多器官联合移植的免疫抑制治疗

Immunosuppressive therapy after multiple organ transplantation

腹部多器官联合移植研究进展

Advances of Abdominal Multivisceral Transplantation

方法我院自2001年10月至2005年1月共施行19例腹部多器官联合移植术，其中胰肾联合移植6例、肝肾联合移植12例、肝胰联合移植1例；

Methods From October 2001 to January 2005 , 19 patients received multiorgan transplantation in Nanfang Hospital , including 6 with simultaneous kidney-pancreas transplantation ( SKPT ), 12 with combined liver-kidney transplantation ( CLKT ), and 1 with simultaneous liver-pancreas transplantation ( SLPT ) .